Australia Markets open in 3 hrs 12 mins

TFF Pharmaceuticals, Inc. (TFFP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.9100+0.0900 (+4.95%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 5.64M
Enterprise value 2.52M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)24.30
Price/book (mrq)1.06
Enterprise value/revenue 16.61
Enterprise value/EBITDA -0.35

Trading information

Stock price history

Beta (5Y monthly) 1.38
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 315.9500
52-week low 31.5400
50-day moving average 32.6721
200-day moving average 36.2477

Share statistics

Avg vol (3-month) 346.23k
Avg vol (10-day) 333.52k
Shares outstanding 53.1M
Implied shares outstanding 6N/A
Float 82.68M
% held by insiders 12.80%
% held by institutions 115.68%
Shares short (15 May 2024) 4128.03k
Short ratio (15 May 2024) 43.22
Short % of float (15 May 2024) 44.19%
Short % of shares outstanding (15 May 2024) 44.13%
Shares short (prior month 15 Apr 2024) 469.73k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-2,848.82%

Management effectiveness

Return on assets (ttm)-93.98%
Return on equity (ttm)-182.42%

Income statement

Revenue (ttm)885.72k
Revenue per share (ttm)0.44
Quarterly revenue growth (yoy)295.30%
Gross profit (ttm)N/A
EBITDA -20.08M
Net income avi to common (ttm)-19.93M
Diluted EPS (ttm)-9.3800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.21M
Total cash per share (mrq)1.04
Total debt (mrq)95.16k
Total debt/equity (mrq)1.79
Current ratio (mrq)1.26
Book value per share (mrq)2.11

Cash flow statement

Operating cash flow (ttm)-14.82M
Levered free cash flow (ttm)-7.26M